Three scientists win Nobel Prize for controlling brain cells with light

Optogenetics breakthrough traced to a light-sensing protein in a single-celled alga

By LineZotpaper

Published20 October 2026

Read Time3 min

Karl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their work on optogenetics, the technique that lets scientists switch nerve cells on and off with light. The prize recognises research into light-gated ion channels that began with a humble question: how does a single-celled alga swim toward light?

The Nobel Committee honoured the three scientists for their research into "light-gated ion channels and optogenetics," a method that has transformed the study of the brain and nervous system.

Hegemann, at Humboldt University of Berlin, and Nagel, at the University of Würzburg, were investigating how the single-celled alga Chlamydomonas senses light. They discovered that the organism relies on a single protein called channelrhodopsin, built into the alga's outer membrane. The protein contains a molecule called retinaldehyde, which absorbs light and changes shape, opening a tiny passage that lets positively charged particles such as sodium flow into the cell. That movement of charged particles sends a signal that helps the alga swim.

The connection to medicine came from the way nerve cells work. Nerve cells also use the movement of charged particles across their membranes to control their activity. The researchers realised that if channelrhodopsin could be placed into nerve cells, those cells could be switched on simply by shining light on them. Deisseroth, a psychiatrist and bioengineer at Stanford University in California, joined Hegemann and Nagel in putting that idea into practice.

Today, scientists use viruses altered to be harmless to deliver the gene for channelrhodopsin into specific nerve cells. In animal studies, light is shone into the brain through a thin optical fibre, activating only the cells that carry the protein. Because light can be aimed at a very small part of the brain and switched on and off rapidly, optogenetics lets researchers test whether particular groups of nerve cells are involved in memory, sleep, sensation or movement.

In one experiment in 2012, a team at the Massachusetts Institute of Technology gave mice a mild electric shock in a particular cage and used optogenetics to tag the nerve cells active during that fear-conditioning experiment. Days later, in a different cage, switching those cells on with light made the mice freeze in fear, as if they remembered the shock. Deisseroth was one of the study's authors.

Optogenetics is already in early-stage clinical trials for people with retinal degeneration, where light-sensitive proteins are introduced into surviving retinal nerve cells to restore some vision. Researchers are also investigating whether the technique could eventually treat neurological conditions including Parkinson's disease and epilepsy.

The Nobel prize also carries a broader message: the discovery began with a question that had no obvious practical importance. The success of optogenetics illustrates the value of asking basic questions about the world, the prize's citation suggests, because it is impossible to predict where knowledge will lead.

Analysis

Why This Matters

Optogenetics gives neuroscientists an unprecedented tool to switch specific groups of nerve cells on and off, making it possible to test their roles in memory, movement, sensation and disease.
The prize highlights how fundamental curiosity-driven research can produce technologies with real medical potential, including early trials to restore vision.
If the technique advances, it could open new treatment pathways for neurological conditions such as Parkinson's disease and epilepsy.

Background

Optogenetics combines optics and genetics: it uses light-sensitive proteins from organisms like algae to control the activity of living cells. The approach emerged from basic biological research into how single-celled creatures sense and respond to light, and was later adapted for use in nerve cells. Nobel Prizes in Physiology or Medicine are often awarded to discoveries that open new fields of research, and optogenetics has become a standard laboratory technique across neuroscience since its development.

Key Perspectives

Neuroscientists: For researchers studying the brain, optogenetics offers a fast, precise and reversible way to test whether particular circuits drive specific behaviours, a major advance over older methods that were slower or less targeted.

Clinicians and patients: For people with retinal degeneration, early-stage trials using light-sensitive proteins offer a possible route to partial vision restoration. Researchers are also watching whether the approach can be developed into treatments for Parkinson's disease and epilepsy.

Critics and sceptics: Delivering genes into the body carries safety challenges, including immune responses and long-term effects of viral vectors. The step from a powerful laboratory tool to a safe, reliable therapy for complex brain disorders remains substantial and unproven.

What to Watch

Results from early-stage clinical trials using optogenetics to restore vision in people with retinal degeneration.
Whether research moves from animal studies toward clinical applications for Parkinson's disease or epilepsy.
How widely and quickly the technique is adopted and refined across neuroscience laboratories worldwide.

Sources

Scientists win 2026 Nobel Prize for controlling brain cells with light · Latest Science News -- ScienceDaily

Checked

9 claims in this story checked against 1 source: 9 supported.

Show each claim

SupportedThree scientists win Nobel Prize for controlling brain cells with lightLatest Science News -- ScienceDaily: “Scientists who worked out how to control brain cells with light have won this year’s Nobel prize in physiology or medicine. Karl Deisseroth, Peter Hegemann and Georg Nagel were honored.”
SupportedOptogenetics breakthrough traced to a light-sensing protein in a single-celled algaLatest Science News -- ScienceDaily: “A surprising discovery in a tiny, light-sensitive alga has transformed neuroscience”
SupportedKarl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their work on optogeneticsLatest Science News -- ScienceDaily: “Scientists who worked out how to control brain cells with light have won this year’s Nobel prize in physiology or medicine. Karl Deisseroth, Peter Hegemann and Georg Nagel were honored.”
SupportedThe Nobel Committee honoured the three scientists for their research into 'light-gated ion channels and optogenetics'Latest Science News -- ScienceDaily: “were honored for their research into “light-gated ion channels and optogenetics.””
SupportedHegemann and Nagel discovered that Chlamydomonas relies on a single protein called channelrhodopsin built into the outer membraneLatest Science News -- ScienceDaily: “Hegemann and Nagel discovered that Chlamydomonas has a beautifully ingenious mechanism of light detection that relies on a single protein called channelrhodopsin. Channelrhodopsin is built into the outer membrane of the algal cell.”
SupportedThe protein contains retinaldehyde which absorbs light and changes shape, opening a passage for positively charged particles like sodiumLatest Science News -- ScienceDaily: “The protein also contains a small molecule called retinaldehyde, which is able to absorb light. When light hits the retinaldehyde inside channelrhodopsin, it changes shape. This makes the channelrhodopsin protein change shape too. That change opens a tiny passage through the cell membrane. Positively charged particles, including sodium, can then flow from the water outside the alga into the cell.”
SupportedIn a 2012 experiment, a MIT team gave mice a mild electric shock and used optogenetics to tag nerve cells; days later, switching those cells on with light made the mice freeze in fear; Deisseroth was a study authorLatest Science News -- ScienceDaily: “In one experiment in 2012, a team at the Massachusetts Institute of Technology gave mice a mild electric shock in a particular cage. They used optogenetics to tag the nerve cells in the brain’s memory center that were active during that the fear-conditioning experiment. Days later, in a different cage, they switched those cells on with light. The mice froze in fear, as if they remembered the shock. ... Deisseroth was one of the study’s authors.”
SupportedOptogenetics is already in early-stage clinical trials for retinal degeneration, and researchers are investigating its use for Parkinson's and epilepsyLatest Science News -- ScienceDaily: “Optogenetics is already in early-stage clinical trials for people with retinal degeneration. ... Researchers are also investigating whether optogenetics could eventually be used to treat neurological conditions, including Parkinson’s and epilepsy.”
SupportedThe Nobel prize carries a broader message that the discovery began with a question with no obvious practical importance, illustrating the value of basic researchLatest Science News -- ScienceDaily: “This year’s Nobel prize celebrates work that started with a question that may sound esoteric: how do Chlamydomonas swim toward light? This question has no obvious practical importance. ... The success of optogenetics is an illustration of the importance of continuing to ask questions simply to understand the world around us because it’s impossible to predict where knowledge will lead.”